Osteovar Oxandrolone Tablets USP 10mg

Osteovar Oxandrolone Tablets USP 10mg | NexorinPharma

Osteovar is an oral anabolic steroid containing 10mg of Oxandrolone per tablet. At NexorinPharma, we carry Osteovar as part of our oral anabolic steroid inventory for customers in markets where Oxandrolone is legally available.

Oxandrolone is one of the most clinically documented anabolic steroids available. Unlike most anabolic steroids discussed in performance communities, Oxandrolone carries active FDA approval for specific medical indications and has a well-established clinical research base spanning several decades. The USP designation on Osteovar indicates that the product meets United States Pharmacopeia standards for pharmaceutical grade compound identity and purity.

Like all anabolic-androgenic steroids, Osteovar carries significant health and legal considerations. This page covers what Oxandrolone is, how it works, and what health and legal considerations apply. It does not constitute medical advice. It does not recommend or encourage steroid use. It does not provide dosage, cycle, or stacking guidance of any kind.

Product Specifications

Website: nexorinpharma.com Product Name: Osteovar Oxandrolone Tablets USP Active Compound: Oxandrolone Also Known As: Anavar, Var Drug Class: Anabolic-androgenic steroid, 17-alpha alkylated oral steroid, DHT derivative Concentration: 10mg per tablet Presentation: Oral tablet Form: Tablet Half-Life: Approximately 9 to 10 hours Route of Administration: Oral Anabolic Rating: 322 to 630 relative to testosterone baseline of 100 Androgenic Rating: 24 relative to testosterone baseline of 100 Aromatization: None 17-Alpha Alkylated: Yes Liver Toxicity: Mild to moderate USP Designation: Yes Legal Status: Schedule III controlled substance in the United States. Prescription required. Legal status varies by country.

What Is Oxandrolone

Oxandrolone is a synthetic anabolic-androgenic steroid derived from Dihydrotestosterone. Searle Laboratories developed it in 1962 and introduced it to the US market under the brand name Anavar in 1964. From the beginning, it was developed with a focus on producing a compound with strong anabolic activity and minimal androgenic effects relative to its anabolic potency.

Structurally, Oxandrolone is a modified form of DHT. Two key structural modifications define it. First, a methyl group at the 17-alpha position allows it to survive first-pass liver metabolism when taken orally. Second, an oxygen atom replaces the carbon-2 atom in the A-ring of the steroid structure. This second modification is directly responsible for Oxandrolone’s unusually high anabolic-to-androgenic ratio and its resistance to aromatization.

These structural characteristics produce an oral anabolic steroid with an anabolic rating of 322 to 630 and an androgenic rating of only 24 relative to a testosterone baseline of 100. Strong anabolic activity combined with very low androgenic potency and no estrogenic conversion defines Oxandrolone’s pharmacological profile and drives its consistent discussion in both clinical and performance communities.

How Oxandrolone Works

Oxandrolone is active when taken orally. The 17-alpha alkylation allows it to pass through the liver without complete breakdown, reaching systemic circulation in active form.

Androgen Receptor Binding

Oxandrolone binds to androgen receptors throughout the body. Its androgenic activity is significantly lower than testosterone despite its high anabolic rating. As a result, androgen receptor activation in muscle tissue drives its anabolic effects while producing comparatively minimal androgenic activity in androgen-sensitive tissues like skin and hair follicles.

Nitrogen Retention

Oxandrolone produces positive nitrogen retention in muscle tissue. The body retains more nitrogen than it excretes. As a result, this supports an anabolic environment that favors muscle repair and preservation. This mechanism is particularly relevant in clinical contexts where muscle wasting prevention is a primary treatment goal.

Protein Synthesis

Oxandrolone accelerates protein synthesis in skeletal muscle tissue. Faster protein synthesis supports muscle repair and growth following training or tissue stress. This mechanism is directly tied to its anabolic receptor activity and contributes to its documented clinical efficacy in muscle wasting conditions.

No Aromatization

Oxandrolone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase. Consequently, estrogen-related side effects including water retention and gynecomastia are not part of its direct pharmacological profile. This characteristic distinguishes Oxandrolone from testosterone and many other anabolic steroids where estrogenic conversion is a primary side effect consideration.

IGF-1 Stimulation

Oxandrolone increases Insulin-like Growth Factor 1 production. IGF-1 plays a direct role in muscle repair, recovery, and anabolic activity throughout the body. This mechanism contributes to the muscle preservation and recovery effects documented in Oxandrolone clinical research.

Creatine Phosphate Synthesis

Oxandrolone enhances creatine phosphate synthesis in muscle tissue. Creatine phosphate is a primary energy substrate for high-intensity muscular activity. As a result, enhanced creatine phosphate availability supports strength and power output during physical activity.

Clinical Background

Oxandrolone carries a more extensive clinical history than virtually any other anabolic steroid discussed in performance communities. Understanding this clinical background provides important context for its pharmacological profile and documented effects.

FDA Approval and Current Indications

The FDA approved Oxandrolone under the brand name Oxandrin, currently produced by Savient Pharmaceuticals. Unlike most anabolic steroids, Oxandrolone retains active FDA approval today. Its current approved indications include weight regain following involuntary weight loss associated with surgery, chronic infection, trauma, or prolonged corticosteroid use, as well as treatment of bone pain associated with osteoporosis.

HIV and AIDS-Related Muscle Wasting

Oxandrolone has extensive clinical research documentation in the treatment of HIV and AIDS-related muscle wasting. Multiple controlled clinical trials have documented its efficacy in preserving and restoring lean body mass in HIV-positive patients experiencing involuntary weight loss. This clinical application represents one of the most well-documented uses of any anabolic steroid in modern medical research.

Burns and Wound Healing

Clinical research has documented Oxandrolone’s efficacy in accelerating recovery and preserving lean body mass in severe burn patients. Studies in pediatric and adult burn patients have demonstrated meaningful improvements in recovery outcomes with Oxandrolone use under medical supervision. As a result, burn treatment represents one of its most consistently supported clinical applications.

Turner Syndrome

Oxandrolone has been studied and used clinically in girls with Turner syndrome to promote linear growth. This pediatric application reflects its documented low androgenic activity and relative safety profile compared to other anabolic steroids at appropriate clinical doses.

Alcoholic Hepatitis

Clinical research has examined Oxandrolone in the treatment of alcoholic hepatitis, a context where its anabolic properties and relatively mild liver impact compared to other oral anabolic steroids make it a relevant research compound. This represents a distinct clinical application outside of muscle wasting and growth indications.

About the USP Designation

The USP designation on Osteovar indicates that the Oxandrolone compound used in this product meets United States Pharmacopeia standards for compound identity, strength, quality, and purity. This designation is relevant context for evaluating Osteovar compared to non-USP anabolic steroid preparations in non-prescription markets.

What USP Means

The United States Pharmacopeia is an independent scientific organization that sets public standards for medicines, food ingredients, and dietary supplements. A USP designation indicates that the active compound meets established standards for identity confirmation, potency, purity, and quality. In the context of non-prescription anabolic steroid products, a USP designation provides a higher standard of compound quality documentation than non-designated preparations.

Non-Prescription Market Context

Despite the USP designation, Osteovar is produced for non-prescription markets where Oxandrolone is legally available. It does not carry the full manufacturing oversight, regulatory scrutiny, or clinical documentation of pharmaceutical grade FDA-approved prescription products like brand-name Oxandrin. The USP designation addresses compound quality standards while the broader manufacturing context remains non-prescription in nature.

About the 10mg Concentration

The 10mg per tablet concentration of Osteovar is a standard clinical dose format for Oxandrolone. This aligns with clinical dosing frameworks used across Oxandrolone’s approved medical applications.

Alignment With Clinical Dosing

The FDA-approved Oxandrin product is available in 2.5mg and 10mg tablet formats. Osteovar’s 10mg concentration therefore aligns with the upper end of the standard pharmaceutical clinical tablet format for Oxandrolone. This alignment with clinical dosing distinguishes Osteovar from anabolic steroid preparations that significantly exceed standard clinical concentration ranges.

Comparison With Other Oxandrolone Formats

Higher concentration Oxandrolone tablets of 20mg, 25mg, and 50mg are produced by various manufacturers in non-prescription markets. The 10mg format of Osteovar represents a concentration consistent with clinical pharmaceutical standards rather than the higher concentration formats produced exclusively for non-prescription performance markets.

Osteovar Versus Other Oral Anabolic Steroids

Versus Methandrostenolone (Dianabol)

Methandrostenolone is a 17-alpha alkylated oral anabolic steroid that aromatizes significantly to estrogen. It carries significant liver toxicity, pronounced estrogenic side effects, and a more aggressive overall side effect profile compared to Oxandrolone. Osteovar produces no estrogenic conversion, lower liver stress, and significantly lower androgenic activity. As a result, Oxandrolone represents a considerably milder pharmacological profile than Methandrostenolone across virtually all side effect parameters.

Versus Oxymetholone (Anadrol)

Oxymetholone is one of the most potent oral anabolic steroids available. It carries significant liver toxicity and pronounced estrogenic effects despite not directly aromatizing. Compared to Oxymetholone, Osteovar produces dramatically lower liver stress, no estrogenic conversion, and a significantly more favorable side effect profile overall. Oxymetholone is generally considered one of the most aggressive oral anabolic steroids while Oxandrolone occupies the opposite end of the oral anabolic steroid potency and risk spectrum.

Versus Stanozolol (Winstrol)

Stanozolol is a non-aromatizing oral anabolic steroid with documented clinical history. Both Stanozolol and Oxandrolone are DHT derivatives that do not convert to estrogen. However, Stanozolol carries more significant liver toxicity and more pronounced adverse lipid effects than Oxandrolone. In addition, Stanozolol’s androgenic activity is higher than Oxandrolone’s very low androgenic rating of 24. Osteovar consequently represents a milder profile than Stanozolol across liver and androgenic side effect parameters.

Versus Turinabol

Turinabol is a non-aromatizing oral anabolic steroid with a moderate anabolic profile and cleaner side effect profile than Methandrostenolone. Both Turinabol and Oxandrolone are non-aromatizing oral compounds. However, Oxandrolone carries active FDA approval and a more extensive clinical research base than Turinabol. Furthermore, Oxandrolone’s anabolic rating significantly exceeds Turinabol’s more moderate anabolic activity.

Versus Mesterolone (Proviron)

Mesterolone is a non-17-alpha alkylated oral androgen with very low liver toxicity. Unlike Oxandrolone, Mesterolone does not carry significant anabolic activity and serves primarily as an androgenic and ancillary compound rather than a primary anabolic agent. Osteovar carries significantly higher anabolic activity than Mesterolone. However, Mesterolone’s non-alkylated structure produces a lower liver stress profile than Oxandrolone’s 17-alpha alkylated formulation.

Side Effects and Health Risks

Osteovar carries a side effect profile that is generally considered milder than most oral anabolic steroids. However, these risks remain real and should not be minimized.

Liver Toxicity

Oxandrolone is a 17-alpha alkylated oral steroid. The alkylation that allows oral bioavailability places stress on liver tissue. However, Oxandrolone’s liver toxicity is consistently documented as milder than other 17-alpha alkylated oral anabolic steroids including Methandrostenolone, Stanozolol, and Oxymetholone. Elevated liver enzymes are possible with Oxandrolone use. Therefore, liver monitoring through regular blood work remains a relevant health consideration despite its comparatively mild hepatotoxicity profile.

Cardiovascular Effects

Oxandrolone produces adverse lipid profile changes. HDL cholesterol decreases while LDL cholesterol increases. These lipid changes are documented in clinical research across Oxandrolone’s approved indications. In addition, the cardiovascular impact of Oxandrolone’s lipid effects is a primary concern given that lipid dysregulation carries long-term cardiovascular health implications. Regular lipid monitoring is therefore important for anyone using this compound.

Androgenic Effects

Despite its very low androgenic rating of 24, Oxandrolone still produces androgenic side effects in susceptible individuals. These include accelerated hair loss in genetically predisposed individuals and acne. In women, virilization risks including voice deepening and clitoral enlargement are serious considerations even at lower doses given Oxandrolone’s anabolic potency.

Hormonal Suppression

Oxandrolone suppresses the hypothalamic-pituitary-gonadal axis and the body’s natural testosterone production. The degree of suppression is generally considered less pronounced than with more potent anabolic steroids. However, post-use hormonal disruption remains a relevant consideration. In some cases, it results in hypogonadism requiring medical treatment.

Psychological Effects

Anabolic steroid use carries documented associations with mood changes and irritability. These considerations apply to Oxandrolone use. They are generally less pronounced than with higher androgenic compounds but remain relevant health considerations.

Legal and Regulatory Status

Oxandrolone retains active FDA approval under the brand name Oxandrin for specific clinical indications. Outside of those indications, however, it carries Schedule III controlled substance status in the United States. Possession without a valid prescription is a federal offense.

In the United Kingdom, Oxandrolone falls under Class C of the Misuse of Drugs Act. Supply is illegal.

The World Anti-Doping Agency bans Oxandrolone alongside all major athletic governing bodies. It appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of Oxandrolone in your specific jurisdiction before purchasing from NexorinPharma.

Frequently Asked Questions

Is Osteovar Available at NexorinPharma

Yes. NexorinPharma carries Osteovar Oxandrolone Tablets USP 10mg for customers in markets where Oxandrolone is legally available. Visit nexorinpharma.com to check current availability and pricing.

What Does the USP Designation Mean for Osteovar

The USP designation indicates that the Oxandrolone compound in Osteovar meets United States Pharmacopeia standards for compound identity, potency, purity, and quality. This provides a higher standard of compound quality documentation than non-USP anabolic steroid preparations in non-prescription markets.

What Is the Half-Life of Oxandrolone

Oxandrolone produces a half-life of approximately 9 to 10 hours. As a result, active plasma concentrations are sustained for longer than shorter half-life oral anabolic steroids while still requiring regular oral administration to maintain stable levels.

Does Oxandrolone Aromatize

No. Oxandrolone does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase. Consequently, estrogen-related side effects are not part of its direct pharmacological profile.

How Does Osteovar Compare to Other Oral Anabolic Steroids in Terms of Liver Toxicity

Oxandrolone carries milder liver toxicity than most other 17-alpha alkylated oral anabolic steroids. Clinical research across its approved indications documents comparatively lower hepatotoxicity than compounds like Methandrostenolone, Stanozolol, and Oxymetholone. However, liver monitoring remains a relevant health consideration for anyone using any 17-alpha alkylated oral compound.

What Are the Most Serious Health Risks

Cardiovascular effects from lipid dysregulation are among the most clinically significant concerns with Oxandrolone. In addition, hormonal suppression, androgenic effects, and liver enzyme elevation complete the primary risk profile. Medical supervision and regular blood work monitoring are therefore essential for anyone using this compound.

Is Osteovar Legal to Purchase

Oxandrolone carries Schedule III controlled substance status in the United States and requires a valid prescription despite retaining active FDA approval for specific indications. Legal status varies by jurisdiction. You are responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.

What to Consider Before Purchasing Osteovar

Osteovar Oxandrolone 10mg has one of the most extensive clinical research bases of any anabolic steroid discussed in performance communities. Its active FDA approval, documented clinical applications across multiple indications, and decades of controlled clinical trial data provide a substantially stronger research foundation than most anabolic steroids carry.

The Osteovar non-prescription format does not carry the full manufacturing oversight of FDA-approved pharmaceutical grade Oxandrin. However, the USP designation provides a higher compound quality standard than non-designated non-prescription anabolic steroid preparations. The clinical research base for Oxandrolone applies to its pharmacological profile and risk profile regardless of the specific manufacturer or format.

Oxandrolone carries documented cardiovascular, liver, hormonal, androgenic, and psychological health risks. These risks require medical supervision to manage responsibly. Regular blood work monitoring including liver enzymes, lipid panels, and hormone levels is essential for anyone using this compound.

For customers in markets where Oxandrolone is legally available, visit nexorinpharma.com to check current Osteovar availability, pricing, and stock levels.